Cytodyn Inc (CYDY)

[Borel Fields]

We already have 394 patients in a randomized longhaulers study - it's called the "follow-up period" of the CD-12 trial.

At least two endpoints of the new longhaulers trial can be self- or telephonically-assessed: primary Fatigue Severity Score and secondary Mental Fatigue Questionnaire.

Call all the CD-12 enrollees! Create one cohort for each week's enrollees and chart the weekly averages for controls and treated.

At worst, we'll know what to expect from the new trial. At best, if we can get the FDA to formally include these endpoints in follow-up (and the caller is kept blinded, etc.) this large trial may be a strong complement to our smaller, de-novo Phase 2 trial in arguing for early use.